Long-term follow-up of Iranian male patients with systemic lupus erythematosus

被引:0
|
作者
Abbas Smiley
Mohammad Matinfar
Alimohammad Fatemi
机构
[1] New York Medical College,Westchester Medical Center
[2] Isfahan University of Medical Sciences,Rheumatology Section, Department of Internal Medicine, School of Medicine
来源
关键词
Systemic lupus erythematosus; Male; Survival; Outcome;
D O I
暂无
中图分类号
学科分类号
摘要
This study was conducted to investigate the long-term survival in male patients with systemic lupus erythematosus (SLE) and its predictors. The main demographic and clinical manifestations at the time of disease diagnosis were recorded retrospectively. Kaplan–Meier curves were used to calculate survival rates. Predictors of mortality were determined by backward Cox regression analysis. Eighty-four male patients with SLE were enrolled. During the 23-year study period, 11 patients died. Lupus nephritis (5 cases), infections (5 cases) and alveolar hemorrhage (1 case) were the most common causes of deaths. Overall survival rates at the end of 5, 10, 15, and 20 years after SLE disease diagnosis were 86%, 84%, 84% and 84%, respectively. In multivariate backward-regression analysis, the main determinants of death at the time of SLE diagnosis were oral ulcer (p = 0.004, HR = 7.69, 95% CI 1.92–33.33), thrombocytopenia (p = 0.012, HR = 5, 95% CI 1.41–16.66) and SLE disease activity index (SLEDAI, p = 0.05, HR = 1.08, 95% CI = 0.999–1.1). Observing oral ulcer, thrombocytopenia and high SLEDAI at the time of disease diagnosis were the main prognostic factors in male lupus patients.
引用
收藏
页码:3399 / 3406
页数:7
相关论文
共 50 条
  • [41] Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort
    Segura, Beatriz Tejera
    Bernstein, Brett Sydney
    McDonnell, Thomas
    Wincup, Chris
    Ripoll, Vera M.
    Giles, Ian
    Isenberg, David
    Rahman, Anisur
    RHEUMATOLOGY, 2020, 59 (03) : 524 - 533
  • [42] A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus
    Wang, Dandan
    Zhang, Huayong
    Liang, Jun
    Wang, Hong
    Hua, Bingzhu
    Feng, Xuebing
    Gilkeson, Gary S.
    Farge, Dominique
    Shi, Songtao
    Sun, Lingyun
    STEM CELL REPORTS, 2018, 10 (03): : 933 - 941
  • [43] A long-term follow-up of male alcohol abuse
    Vaillant, GE
    ARCHIVES OF GENERAL PSYCHIATRY, 1996, 53 (03) : 243 - 249
  • [44] Modelling long-term outcomes for patients with systemic lupus erythematosus
    Touma, Z.
    Kayaniyil, S.
    Parackal, A.
    Bonilla, D.
    Su, J.
    Johnston, A.
    Gahn, J.
    Hille, E. D.
    Ohsfeldt, R.
    Chandran, S.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 68
  • [45] Long-term cardiac changes in patients with systemic lupus erythematosus
    De Godoy M.F.
    De Oliveira C.M.
    Fabri V.A.
    De Abreu L.C.
    Valenti V.E.
    Pires A.C.
    Raimundo R.D.
    Figueiredo J.L.
    Bertazzi G.R.L.
    BMC Research Notes, 6 (1)
  • [46] Long-term follow-up after lymphodepleting autologous haematopoietic cell transplantation for treatment-resistant systemic lupus erythematosus
    Goklemez, Sencer
    Hasni, Sarfaraz
    Hakim, Frances T.
    Muraro, Paolo A.
    Pirsl, Filip
    Rose, Jeremy
    Memon, Sarfraz
    Fowler, Daniel F.
    Steinberg, Seth M.
    Baker, Eva H.
    Panch, Sandya R.
    Gress, Ronald
    Illei, Gabor G.
    Lipsky, Peter E.
    Pavletic, Steven Z.
    RHEUMATOLOGY, 2022, 61 (08) : 3317 - 3328
  • [47] EFFECT OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS DURING LONG-TERM FOLLOW-UP
    Tsanyan, M.
    Soloviev, S.
    Radenska-Lopovok, S.
    Aleksandrova, E.
    Nikolaeva, E.
    Khrennikov, Y.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 78 - 78
  • [48] Withdrawal of therapy in patients with proliferative lupus nephritis: long-term follow-up
    Moroni, G
    Gallelli, B
    Quaglini, S
    Banfi, G
    Rivolta, E
    Messa, P
    Ponticelli, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (06) : 1541 - 1548
  • [49] Open-label infliximab for systemic lupus erythernatosus: long-term follow-up of 11 patients.
    Aringer, Martin
    Houssiau, Frederic A.
    Graninger, Winfried B.
    Steiner, Guenter
    Smolen, Josef S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S260 - S261
  • [50] LONG-TERM PROGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS
    LEONHARDT, T
    ACTA MEDICA SCANDINAVICA, 1966, S179 : 440 - +